Barclays CEO diagnosed with non-Hodgkin lymphoma

by | Nov 28, 2022

Banking giant Barclays said on Monday that chief executive CS Venkatakrishnan will be undergoing treatment for non-Hodgkin lymphoma.

Barclays stated Venkatakrishnan will undergo treatment at Memorial Sloan Kettering Cancer Center in New York, with his condition labelled as being curable with the hospital’s prescribed regimen.

However, he said he will have to work from home “for some periods” and not be able to travel.

“The board has been kept apprised of my situation and I am enormously grateful for their support,” said Venkatakrishnan.

“We have a highly capable and seasoned executive committee, supported by a talented senior management team. I am very confident that we will continue, with your help, to serve our customers and clients well, and produce strong operating performance for our shareholders.”

As of 1020 GMT, Barclays shares were up 0.50% at 159.86p.

Reporting by Iain Gilbert at Sharecast.com

Related articles

Ryanair passenger numbers jump 9% in December

Ryanair passenger numbers jump 9% in December

(Sharecast News) - Budget airline Ryanair reported a 9% jump in December passenger numbers on Wednesday. Traffic rose to 12.54 million from 11.52m in the same month a year earlier, while the load factor - which gauges how full the planes are - ticked down to 91% from...

Wizz Are passenger numbers soar in December

Wizz Are passenger numbers soar in December

(Sharecast News) - Hungary-based budget airline Wizz Air reported a strong rise in December passenger numbers as demand continued to rebound from the Covid pandemic. The company on Wednesday said it carried 4,964,857 passengers, an 18.8% increase year on year. For the...

Trending stories

Join our mailing list

Subscribe to our mailing list to receive regular updates!

x